⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Naveen ManchandaMD

Hematology-Oncology · Indianapolis, IN 46202

NPI: 1881750313

Share:𝕏fin

30

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers90th percentile opioid prescribing

Risk indicators are statistical patterns, not allegations. Learn more

578

Total Claims

$383K

Drug Cost

88

Beneficiaries

$4,351

Cost/Patient

Risk Score Breakdown 30/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+5

Score components are additive. Read full methodology

Peer Comparison vs. 8,541 Hematology-Oncology providers

+617%

Opioid rate vs peers

45.0% vs 6.3% avg

-68%

Cost per patient vs peers

$4,351 vs $14K avg

+170%

Brand preference vs peers

39.4% vs 14.6% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

45.0%

Opioid Rate

260

Opioid Claims

$11K

Opioid Cost

19.6%

Long-Acting Rate

This provider's opioid prescribing rate of 45.0% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

61% generic

Brand: 228 claims · $245K

Generic: 350 claims · $138K

Patient Profile

60

Avg Age

61%

Female

3.08

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About